4//SEC Filing
Mayer Eldon C. III 4
Accession 0001140361-23-010158
CIK 0001305253other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:49 PM ET
Size
5.1 KB
Accession
0001140361-23-010158
Insider Transaction Report
Form 4
Mayer Eldon C. III
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-03-01+98,000→ 98,000 totalExercise: $1.71Exp: 2033-02-28→ Common Stock (98,000 underlying)
Footnotes (1)
- [F1]. The option vests in 48 equal monthly installments commencing on the grant date of March 1, 2023, subject to the Reporting Person's continuous service as of such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001686952
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:49 PM ET
- Size
- 5.1 KB